MC1013A1 - Nouveaux composés hétérocycliques et leurs procédés de préparation - Google Patents

Nouveaux composés hétérocycliques et leurs procédés de préparation

Info

Publication number
MC1013A1
MC1013A1 MC1097A MC1097A MC1013A1 MC 1013 A1 MC1013 A1 MC 1013A1 MC 1097 A MC1097 A MC 1097A MC 1097 A MC1097 A MC 1097A MC 1013 A1 MC1013 A1 MC 1013A1
Authority
MC
Monaco
Prior art keywords
group
amino
carbon atoms
lower alkyl
formula
Prior art date
Application number
MC1097A
Other languages
English (en)
French (fr)
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of MC1013A1 publication Critical patent/MC1013A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/69Two or more oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
MC1097A 1973-02-20 1974-02-19 Nouveaux composés hétérocycliques et leurs procédés de préparation MC1013A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH244473A CH584209A5 (en) 1973-02-20 1973-02-20 3-amino-2-hydroxypropoxy substd. diazines and pyridines - with beta-adrenergic blocking or stimulating activity

Publications (1)

Publication Number Publication Date
MC1013A1 true MC1013A1 (fr) 1974-10-18

Family

ID=4233957

Family Applications (1)

Application Number Title Priority Date Filing Date
MC1097A MC1013A1 (fr) 1973-02-20 1974-02-19 Nouveaux composés hétérocycliques et leurs procédés de préparation

Country Status (9)

Country Link
JP (2) JPS5823666A (enExample)
CH (1) CH584209A5 (enExample)
FI (1) FI60391C (enExample)
HU (1) HU173821B (enExample)
MC (1) MC1013A1 (enExample)
NO (1) NO139682C (enExample)
PL (7) PL100171B1 (enExample)
SU (3) SU659089A3 (enExample)
ZA (1) ZA741070B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4517188A (en) * 1983-05-09 1985-05-14 Mead Johnson & Company 1-Pyrimidinyloxy-3-hetaryl-alkylamino-2-propanols
DE4421495A1 (de) * 1994-06-20 1995-12-21 Merck Patent Gmbh Heterocyclyloxy-benzoylguanidine
DE4426346A1 (de) * 1994-07-25 1996-02-01 Basf Ag Herbizide Pyrazinderivate

Also Published As

Publication number Publication date
FI60391B (fi) 1981-09-30
FI60391C (fi) 1982-01-11
CH584209A5 (en) 1977-01-31
SU577978A3 (ru) 1977-10-25
PL100172B1 (pl) 1978-09-30
NO139682C (no) 1979-04-25
SU659089A3 (ru) 1979-04-25
SU593657A3 (ru) 1978-02-15
PL100314B1 (pl) 1978-09-30
PL98964B1 (pl) 1978-06-30
PL98967B1 (pl) 1978-06-30
PL94250B1 (enExample) 1977-07-30
PL100171B1 (pl) 1978-09-30
NO139682B (no) 1979-01-15
JPS5823666A (ja) 1983-02-12
ZA741070B (en) 1975-01-29
JPS603391B2 (ja) 1985-01-28
NO740486L (no) 1974-08-21
HU173821B (hu) 1979-08-28
PL101376B1 (pl) 1978-12-30
JPS5823675A (ja) 1983-02-12

Similar Documents

Publication Publication Date Title
KR890002290B1 (ko) 피페라진 유도체 및 그의 제조방법
DE69633947T2 (de) Zwischenprodukte zur Herstellung von Metallproteinasehemmern
DE69403823T2 (de) Substituierte Phenylsulfonamine als selektive B3-Agonisten zur Behandlung von Diabetes und Fettleibigkeit
EP2114934B1 (en) Composition and methods for modulating a kinase cascade
KR870000354B1 (ko) 피리딘-2-에테르 또는 피리딘-2-티오에테르의 제조방법
DE2406930A1 (de) Neue heterocyclische verbindungen und verfahren zu ihrer herstellung
JP2510839B2 (ja) 薬剤における第一級及び第二級アミン官能基のための生物変換性プロドラッグ成分として有用な新規なn−(アシルオキシ−アルコキシ)カルボニル誘導体類の新規な製造方法
US7462634B2 (en) N-(pyridin-2-yl)-sulfonamide derivatives
US4505910A (en) Amino-pyrimidine derivatives, compositions and use
DE2520910A1 (de) Cyclisch substituierte derivate des 1-amino-2-propanol
EP0130735B1 (en) Amino-pyrimidine derivatives
FR2569694A1 (fr) Derives d'ethylenediaminemonoamide, composition pharmaceutique les contenant et utilisation de ces composes a titre d'antidepresseur ou d'antiparkinsonien
EA022646B1 (ru) Замещенное производное изохинолина
FR2566404A1 (fr) Nouveaux derives de la 1,4-dihydropyridine, leurs sels, procede pour les preparer, et compositions pharmaceutiques les contenant
EP2514748B1 (en) 2,4-diaminoquinazolines for spinal muscular atrophy
KR900001186B1 (ko) 5-치환된-6-아미노피리미딘 유도체의 제조방법
MC1013A1 (fr) Nouveaux composés hétérocycliques et leurs procédés de préparation
DE60216319T2 (de) Heteroaryl-substituierte aminocyclohexan-derivate
DE3876114T2 (de) Benzodioxol-derivate, diese enthaltende zusammensetzungen und deren verwendung zur herstellung von medikamenten.
JP3213576B2 (ja) 置換ピリジン
CA1209142A (fr) Procede d'obtention de nouvelles cyanoguanidines et des compositions pharmaceutiques en renfermant
MC1438A1 (fr) Derives d'oxadiazolopyrimidine
US4410530A (en) 2-(3-Amino-2-hydroxy-propoxy)-mono-and diazines
DD157796A5 (de) Verfahren zur herstellung neuer derivate des 2-amino-aethanols
FR2539412A1 (fr) Derives du 5-fluoruracile et leurs utilisations therapeutiques en tant qu'agents carcinostatiques

Legal Events

Date Code Title Description
YP Annual fee paid